Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome

Date Added
February 7th, 2022
PRO Number
Pro00118200
Researcher
Dorothea Jenkins

List of Studies


Keywords
Infant, Pregnancy
Summary

Neonatal Opioid Withdrawal Syndrome (NOWS) is a condition in which infants undergo withdrawal after exposure to opioids in utero. The current standard of care uses oral morphine and/or methadone which can lead to harmful side effects in the infant. We propose a non-drug based, adjunct treatment that stimulates nerves around the ear, and may help reduce withdrawal symptoms while using less morphine.

Institution
MUSC
Recruitment Contact
Dorothea Jenkins
8437922112
jenkd@musc.edu



-- OR --